Biotechnology News

August 27, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Jay R. Luly,...

August 27, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group comments on inaccurate article. The author disclosed on the front page that he is “short” the Company’s stock, meaning that the author profits if the share price declines.

August 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Madison Vaccines Inc.'s MVI-816 will be used in a trial testing a two-pronged approach to treat metastatic prostate cancer, conducted with a $1.5M Movember-Prostate Cancer Foundation Challenge Award.

August 27, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that a series of abstracts highlighting data from its Infectious Disease portfolio will be presented at the 54th Interscience Conference on Antimicrobial...

August 27, 2014

EAGAN, Minn.--(BUSINESS WIRE)--The National Institutes of Health has awarded a small business innovation research grant to Biothera for the continued development of a fungal vaccine. The $150,000 grant will support the continued preclinical...

August 27, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

August 27, 2014

BOSTON--(BUSINESS WIRE)--CIMIT, the Consortia for Improving Medicine with Innovation & Technology, is proud to have facilitated Boston University’s PharmaChk team in helping to secure $2M grant from Saving Lives At Birth: A Grand Challenge...

August 27, 2014

HORSHAM, England--(BUSINESS WIRE)--Cmed will be speaking and exhibiting at the Outsourcing in Clinical Trials Southern California conference, taking place on September 23-24, 2014 in La Jolla, CA, USA.

August 27, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--MolecularHealth to Sponsor Best of ASCO Florida 2014 Symposium

August 27, 2014

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign...

August 27, 2014

LONDON & AUDUBON, Pa.--(BUSINESS WIRE)--DrugDev President and CEO Ibraheem Mahmood has been named to the 2014 PharmaVOICE 100 list of the most inspirational people in the life sciences industries.

August 27, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) announced that its subsidiary Asterias Biotherapeutics, Inc. (OTCBB:ASTY) has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1/2a clinical...

August 27, 2014

SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte Inc., the company revolutionizing life science research with the Echo® acoustic liquid handler, has been selected by the World Economic Forum as a 2015 Technology Pioneer.

August 27, 2014

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer...

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc. today announced the appointment of Daniel T. Dransfield, Ph.D. as vice president and head of translational medicine.

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following upcoming conferences: FBR Inaugural Healthcare Conference, Boston, MA, September 3rd (no presentation or webcast) Morgan...

August 27, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc has received approval of a supplemental New Drug Application (sNDA) for the once-daily use of Promacta®/Revolade...

August 27, 2014

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing transformative therapeutics using its proprietary ARCUSTM technology, today announced that it has filed a...

August 27, 2014

SAN JOSE, Calif.--(BUSINESS WIRE)--A&D Medical today launched its WellnessConnected® platform to help people monitor their physical activity and manage their health.

August 27, 2014

SAN JOSE, Calif.--(BUSINESS WIRE)--In order to provide consumers with an optimized connected health experience, A&D Medical today announced it has partnered with Salutron.

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for claims in the...

August 27, 2014

SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN has announced the release of a novel targeted enrichment method that, in a single assay, will detect all possible fusion events involving 446 cancer fusion genes as curated by COSMIC.

August 27, 2014

MUNICH, Germany--(BUSINESS WIRE)--New Automatic Brain Metastases Planning* software by Brainlab has been clinically used to successfully deliver fast, efficient radiosurgery treatment to a patient with metastatic brain cancer. The procedure was...

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), announced that company representatives will participate in several investor conferences in September.

August 27, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, Chief Executive Officer, and Andrew A. Hindman, Chief Business Development Officer, will present at Baird’s 2014 Healthcare Conference on...

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of...

August 27, 2014

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc., a biotechnology company focused on developing safer and more effective cellular immunotherapies, today announced the successful completion of a $55M Series C financing. The funding will be...

August 27, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Morgan Stanley Global Healthcare Conference in New York on September 9, 2014. The live webcast is scheduled to begin...

August 27, 2014

SAN DIEGO--(BUSINESS WIRE)--Daylight Solutions, Inc., a leading manufacturer of molecular detection and imaging solutions in the mid-infrared, announced the addition of Dr. Benjamin Bird to the company’s mid-infrared imaging team. Dr. Bird, a...

August 26, 2014

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Optomec, a leading provider of production grade additive manufacturing systems, today announced that the Factory Automation and Production Systems (FAPS) Institute at Friedrich-Alexander-Universität Erlangen-...

August 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) announced today that Mark Perrin, Chief Executive Officer, is scheduled to present at the 2014 Aegis Healthcare Conference to be held September 10-13, 2014 at The Encore...

August 26, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical has been notified by the U.S. Food and Drug Administration (FDA) that issues cited in the Plano, Texas, facility’s warning letter have been addressed.

August 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec in Panel at the Citi 9th Annual Biotech Conference

August 26, 2014

SAN DIEGO--(BUSINESS WIRE)--StemCutis, a Stemedica operating company that develops stem cell therapies for dermatology applications, attracts entrepreneur Ike Lee as CEO and dermatologist Dr. Ronald Wheeland as Director.

August 26, 2014

CLIFTON, N.J.--(BUSINESS WIRE)--mPhase Technologies Launches New Website

August 26, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research, a premier provider of early phase clinical research services, today announced it has added facial recognition software as an additional security feature to its...

August 26, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen N.A. (Euronext: IPN; ADR: IPSEY) today announced that a new supply of Increlex® will be available starting in September 2014. In collaboration with the U.S. Food and Drug Administration (FDA), Ipsen is...

August 26, 2014

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, LLC today announced Dave Bradshaw has joined the company as executive director of manufacturing. In this role, Bradshaw will oversee the manufacturing and supply operations for Marathon...

August 26, 2014

PISCATAWAY, N.J.--(BUSINESS WIRE)--IEEE Addresses E-Health Gap with New Standard for Evaluating Wearable, Cuffless Blood-Pressure Devices

August 26, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDQ: CNCE) today announced that it has achieved a $2 million milestone under its development and license agreement with Avanir Pharmaceuticals, Inc. for the clinical progression...

August 26, 2014

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has received approval from the U.S. Food and Drug Administration for Kabiven® and Perikabiven®, parenteral nutrition (PN) products in a three-chamber bag – the only container...

August 26, 2014

OSLO, Norway--(BUSINESS WIRE)--Please find enclosed the report for the second quarter 2014. Highlights for second quarter 2014: • The lead product candidate Betalutin™ has been granted orphan drug designation for treatment of follicular lymphoma...

August 26, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist to Present New Data from Antibiotics Portfolio at 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

August 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in five...